Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Nextdoor Holdings (KIND) Appoints Marissa Mayer, Niraj Shah, and Robert Hohman to its Board
-
Tyra Biosciences (TYRA) Appoints Susan Moran and S. Michael Rothenberg to its Board
-
Sarahi Espinoza Salamanca Named Knight-Hennessy Scholar
-
Knight-Hennessy Scholars announces its largest cohort yet: 90 new scholars
-
Lumen Technologies (LUMN) Appoints Chad Ho as EVP and Chief Legal Officer
-
Lucid Group (LCID) Announces Resignation of Michael Bell, SVP of Digital
-
Stanford AI Leader Fei-Fei Li Building 'Spatial Intelligence' Startup - Reuters
-
Zuora, Inc. (ZUO) Appoints John D. Harkey, Jr. to its Board
-
Private Sector Employment Increased by 192K vs 180K Expected
-
Stanford Medicine Children's Health Welcomes New Chief of the Division of Abdominal Transplantation
-
Velo3D (VLD) Announces Executive Changes
-
DoorDash (DASH) Appoints Jeffrey Blackburn to its Board
-
How a Social Media Post Led a Teen to Find a 'Kidney Buddy' for Life
-
TG Therapeutics (TGTX) Announces Additional Data Presentations for BRIUMVI in Multiple Sclerosis
-
Rogers $1M Season of Canada’s Got Talent: Top Performances from Tonight’s Episode on Citytv
-
Westamerica Bancorp. (WABC) Appoints Martin Camsey to its Board
-
Sight Sciences (SGHT) Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI Surgical System Tech
-
Wipro (WIT) Appoints Malay Joshi as Chief Executive Officer for Americas 1 Strategic Market Unit
-
Code.org Launches AI Teaching Assistant in Partnership with Stanford
-
Arcutis Biotherapeutics (ARQT) Appoints David Topper as Chief Financial Officer
-
Esperion Therapeutics (ESPR) Presents Important New Data from CLEAR Outcomes at ACC.24
-
Caribou Bioscience (CRBU) Announces FDA Clearance of IND in Lupus
-
Allegro MicroSystems (ALGM) Appoints Jennie Raubacher to its Board
-
ADP Employment Change (Mar) 184K vs 150K Expected
-
Roivant Sciences (ROIV) Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, $1.5B Share Buyback
-
Vertex Pharma (VRTX) Advances Inaxaplin into Phase 3 Portion of Adaptive Phase 2/3 Trial
-
Beyond Meat (BYND) Unveils New and Expanded Line of Beyond Crumble
-
Akebia Therapeutics (AKBA) Receives FDA Approval for Vafseo Tablets
-
Minerals Technologies (MTX) Appoints Kristina M. Johnson to its Board
-
Stanford Medicine Children's Health and Lucile Packard Children's Hospital Stanford Awarded Magnet® Recognition Again
-
Esperion Therapeutics (ESPR) Reports Data from CLEAR Outcomes Sub-Groups as Poster Presentations
-
Scholastic Corp (SCHL) Appoints Alix Guerrier and Kaya Henderson to its Board
-
Alpine Immune Sciences (ALPN) Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
-
monday.com Ltd. (MNDY) names Petra Jenner to board
-
Jasper Therapeutics (JSPR) Announces Additional Positive Data from Phase 1b/2a of briquilimab
-
Outset Medical Inc. (OM) Appoints Brent D. Lang to its Board
-
Immuneering Corporation (IMRX) Appoints Thomas J. Schall, Ph.D. to its Board of Directors
-
Baird Medical to Go Public via Merger with ExcelFin Acquisition (XFIN)
-
Funko (FNKO) Announces Resignation of CFO and COO
-
Cognizant (CTSH) Unveils Artificial Intelligence Lab
-
ADP Employment Change (Feb) 140K vs 150K Expected
-
Canada’s Got Talent Reveals Showstopping Acts for The Million Dollar Season, Courtesy of Rogers
-
Avidity Biosciences (RNA) Reports Positive AOC 1001 Long-term Data
-
Five Point Holdings, LLC (FPH) Appoints Mike Alvarado as COO
-
AT&T (T) Appoints Marissa Mayer to its Board
-
Cadiz (CDZI) Appoints Barbara Lloyd to its Board
-
Madrigal Pharma (MDGL) Appoints Mardi C. Dier as CFO
-
Silicon Labs (SLAB) Appoints Dean Butler as CFO
-
freebeat Joins Elite Stanford StartX 2024 Cohort: A Milestone in Sport Tech Innovation
-
Quince Therapeutics (QNCX) Launches Scientific Advisory Board

